Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer
Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer
原文摘要
出版方登记 · OpenAlexTime-resolved, network-wide consequences of cancer metabolic reprogramming remain poorly understood. We built multi-omics-constrained, near-genome-scale kinetic ensembles for isogenic BRCA1 wild-type and BRCA1-mutant ovarian cancer cells. Covering over 2,100 reactions, the ensembles enabled uncertainty-quantified simulations of nutrient, metabolite, and enzyme perturbations. Metabolic control analysis identified 28 enzyme-mediated vulnerabilities; 24 are linked to experimental or approved DrugBank compounds, whereas four lack documented drug associations. Independent DepMap data supported a subset of these candidates. All 28 emerged directly from the mechanistic model structure and multi-omics constraints, with no calibration to known drug targets or cancer-dependency data. Simulations of thymidylate synthase, hexokinase, and triokinase inhibition predicted target- and physiology-specific changes in pathway use, energy metabolism, and a shared ceramide-linked stress response. Mapping predicted enzyme-activity shifts to BRCA1-associated transcription factors suggested regulatory routes underlying differences between the two states. These ensembles provide a reusable framework for time-resolved, mechanistic hypothesis generation across cancers and other diseases. A record of this paper's transparent peer review process is included in the supplemental information.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
来源:Cell Systems · doi.org